Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
about
Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.Ultra-High Density SNParray in Neuroblastoma Molecular DiagnosticsClinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltrationMetastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.Neuroblastoma: molecular pathogenesis and therapy.Genome instability model of metastatic neuroblastoma tumorigenesis by a dictionary learning algorithm.Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.On the significance of germline cytogenetic rearrangements at MYCN locus in neuroblastomaSegmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settingsBiotensegrity of the extracellular matrix: physiology, dynamic mechanical balance, and implications in oncology and mechanotherapyThe role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.Emerging drugs for neuroblastoma.Mechanisms of neuroblastoma regressionLong noncoding RNAs and neuroblastoma.Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.Translational compensation of genomic instability in neuroblastomaQuantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma.Advances in emerging drugs for the treatment of neuroblastoma.Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort.High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas.Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastomaALK Protein Expression is Related to Neuroblastoma Aggressiveness, But is Not Independent Prognostic Factor.Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations.Fanconi anemia and solid malignancies in childhood: a national retrospective study.Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy.Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors.Neuroblastoma: clinical and biological approach to risk stratification and treatment.Surveillance imaging and radiation exposure in the detection of relapsed neuroblastoma.Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastomaGenomics of adult and pediatric solid tumors
P2860
Q33889856-85B5FEA1-630A-4ADA-AC99-776B3893DFEAQ34032495-FCE8A8CB-3115-47FE-9E0A-3D6578DE56A8Q34226029-E17C0A29-A202-45F2-B3D5-BF304139CC27Q34346730-DBF7756E-082E-4671-AA90-88930B07B990Q35129132-0D609620-7FEF-4CE2-A5A2-4120C4F5C512Q35564199-F559527E-B076-4C2A-93C8-40E2F994E1E0Q35769850-A728F14E-B16D-4DA2-BCCB-7939DDB04241Q37109868-AFDE54AD-AF4E-4525-B742-1F608F2DF725Q37285617-E643B4D2-F152-425D-916C-CF503F347917Q37415141-00F8DB40-5BA9-4F0B-A9BD-8FAB6FEE43C5Q37461968-EA338D40-9872-4582-9081-F4CB7E92B3C2Q37614639-3EE53DA0-3198-4588-9C98-5D3A891668ADQ38070334-FE024D83-C037-4291-A191-F3E3F64EC7DCQ38108399-77D83E9D-18BD-4262-AA6D-25CC91BF5FCAQ38261519-2B7092DC-658E-446C-B4CD-391A2DD43C67Q38531097-086437BA-918E-45DB-85D1-416E316A78E1Q38625880-6FB60A9D-003D-46A4-A6A1-4F1697980A4DQ38684328-76A9C70A-A30D-429A-B47E-D6F888F865EFQ38702196-0AA8CE67-A727-4885-9FE6-3F63B955CC39Q38833093-5D37AC9F-7486-4344-9F5B-02127C45972DQ39064490-B0BCBCC2-7F51-4EE2-A314-1A98B00269C0Q39158415-7AF7C9F0-65E0-4179-80DE-0706EEB33067Q40651848-2E0A265A-97B5-45F3-9C28-69F1E94675E8Q41561035-414218CE-CE26-4317-8995-32CE8D4FA932Q41885084-C387AFC2-C8AF-446C-B0BB-7AED4CD2B314Q42282780-0CAE55CC-25AC-4EC8-B7F2-4D46609A0260Q47712911-09EF10F0-A225-464D-AECC-0C8948840388Q47834857-594011DA-E5BA-42BE-82FE-CCB956C5A387Q47936860-42927BB0-45DC-4145-8E0D-E6B4C86E0345Q48461365-FCB8DB6F-69C8-4FE7-9689-043088D49213Q50079732-3E9BB2F5-DBBB-4952-A23D-5581F0F33972Q50853134-182C17B2-04AD-4977-8A80-CEA9EA12670CQ52639269-536DCAFD-5EDB-468B-BA87-C76F90208CBFQ52982329-9A501B39-0AAB-4D4C-B170-68BE9D0A754AQ53086691-2186F59D-6849-4B0A-9BF8-0509869C2BB7Q58698690-A022672C-08A8-48F7-AC2F-3B383FC595AFQ58804574-40387EBB-F332-481B-AA75-B7C332DBAD3A
P2860
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Segmental chromosomal alterati ...... a report from the INRG project
@ast
Segmental chromosomal alterati ...... a report from the INRG project
@en
type
label
Segmental chromosomal alterati ...... a report from the INRG project
@ast
Segmental chromosomal alterati ...... a report from the INRG project
@en
prefLabel
Segmental chromosomal alterati ...... a report from the INRG project
@ast
Segmental chromosomal alterati ...... a report from the INRG project
@en
P2093
P2860
P356
P1476
Segmental chromosomal alterati ...... a report from the INRG project
@en
P2093
A D J Pearson
A Nakagawara
F Speleman
G M Brodeur
G P Tonini
G Schleiermacher
P2860
P2888
P304
P356
10.1038/BJC.2012.375
P407
P577
2012-09-13T00:00:00Z
P5875
P6179
1052874118